Maydan Rothblum - 29 Feb 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)

Reporting relationship: CFO and COO, Director
Issuer ticker: VRAR
Reported as of: 29 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2024, 10:11:16 UTC
Prior SEC filing: 03 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Maydan Rothblum

Key filing fact

Maydan Rothblum filed Form 4 for Glimpse Group, Inc. (VRAR) on 05 Mar 2024.

Key facts

This page summarizes Maydan Rothblum's Form 4 filing for Glimpse Group, Inc. (VRAR).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Mar 2024, 10:11.

Change

Previous filing in this sequence was filed on 03 Oct 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRAR transaction Derivative

Stock Option (Right to Purchase)

Disposed to Issuer

Transaction value: $0
Shares: -320,180
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 320,180
Exercise price
Footnotes: F1, F2

VRAR transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value: $0
Shares: +306,145
Change %
Price: $0.000000
Shares after: 306,145
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 306,145
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the forfeiture of fully vested options to purchase an aggregate of 320,180 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 25,008 shares of common stock and 8,328 shares of common stock granted on September 1, 2019 and September 1, 2020, respectively, with an exercise price of $4.00/share, (ii) 33,333 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (iii) 8 shares of common stock and 3 shares of common stock granted on September 1, 2020 and January 1, 2021, respectively, with exercise prices of $4.00/share and $4.50 /share, respectively, (iv) 2,333 shares of common stock and 1,167 shares of common stock granted on July 1, 2020 and August 1, 2020, with an exercise price of $4.50/share, and (v) 250,000 shares of common stock granted on June 20, 2017, with an exercise price of $2.50.

Footnote F2

The options in footnote (1) were to expire 10 years from their respective grant dates.

Footnote F3

Mr. Rothblum was granted options to purchase an aggregate of 306,145 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 18,715 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 18,715 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, (iii) options to purchase 18,715 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027, and (iv) options to purchase 250,000 shares of common stock, at an exercise price of $1.50 per share, which vest monthly over 45 months. All of the foregoing options, other than the option to purchase 250,000 shares of common stock, expire seven years from the grant date. The option to purchase 250,000 shares of common stock expires ten years from the grant date.